Protocols are prioritized by search demand and research interest
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
Whats happening: Sleep architecture is shifting
;13(1) Broide E, Bloch O, Ben-Yehudah G, Cantrell D, Shirin H, Rapoport MJ (2013) GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands
Early intervention is critical to slowing and reversing the degenerative process